Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level ll Quote
View:
Post by knoxt on Dec 29, 2021 10:32am

Level ll Quote

THERALASE TECHNOLOGIES INC (CA: TLT)


          
Real-time  

Last: 0.330   Change: -0.005    Volume: 36,665   Last Trade: 09:57  

  Level ll Quote
  Bid   Ask
  Price   Total Size   # of Orders   Price   Total Size   # of Orders
$0.32 20000 3 $0.33 16000 1
$0.315 9000 2 $0.335 16000 1
$0.31 5000 1 $0.34 25000 1
$0.305 15000 3 $0.345 18500 2
$0.30 19000 3 $0.35 45500 4
$0.29 34000 1 $0.36 16000 2
$0.285 27500 1 $0.365 13500 2
$0.28 115500 3 $0.37 24000 2
$0.27 31000 1 $0.375 30000 1
$0.26 7500 2 $0.38 74000 7
 
Comment by robertshaw on Dec 29, 2021 10:43am
Blowjobjoe's bosses still want to dump hard..., guess they will continue to do this until the day we get BTD. So miserable...
Comment by Lesalpes29 on Dec 29, 2021 12:07pm
On the nid at .33. Try to complete my full position before BTD. GL
Comment by Infinity on Dec 29, 2021 12:37pm
Interesting to see that there are 100,000 shares on the ask side that are at or below 0.35 CDN. Assuming that they are selling small volumes and try to buyback the same stock at a lower price.  Not sure if they will even make the broker's commision when they sell and buy such small volume of stock...Unless, ofcourse these are traders who work for brokerage firms that offer discounted ...more  
Comment by Lesalpes29 on Dec 29, 2021 12:58pm
Could be spoofing offers. For accumulation.
Comment by Impalaman on Dec 29, 2021 1:46pm
Last day of tax selling in canada----so that's why the push down ----know that there might be a few more wanting to sell before 4.00 pm------should be pushup days--thursday and friday---MM'S LOOKING FOR CHEAPIES.
Comment by Pandora on Dec 29, 2021 1:46pm
Might have been better after 4 days off if we didn't have to reopen for the last day of tax loss selling. All the laggards dragging it out. Not so much for TLT because it is at or close to one year highs but across the board there seems to be lots of vigorous selling.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250